Phase I – Bioequivalence

295 trials 18 recruiting

Filter these 295 trials by condition, country, sponsor and more.

Open in Search →

Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative … Ended

2025-524035-39-00 Bioavailability study in healthy volunteers under fasti 2026-01-14
A double blinded, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover, bioequivalence study comparing Bupr… Ended

2024-516035-27-00 major depressive illness 2026-01-09
Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fasting Conditions. Ended

2025-522626-12-00 No medical condition. 2025-12-18
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin. Ended

2024-519851-27-00 No medical condition. 2025-12-09
A double blinded, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover, bioequivalence study comparing Bupr… Ended

2024-516034-35-00 major depressive illness 2025-12-05
An open label, randomized, single-dose, two-treatment, two-period, cross-over bioequivalence study comparing Pyridostigmine Bromide, P.R.Tab… Ended

2025-524217-89-00 treatment of myasthenia gravis 2025-12-04
Bioequivalence of Cinnarizine/Dimenhydrinate 20 mg/40 mg Tablets in Healthy Participants Under Fed Conditions. Ended

2025-523948-12-00 No medical condition. 2025-11-27
Comparison of Prefilled syringe and Autoinjector presentations of FYB202 Ended

2025-522422-13-00 Chronic inflammatory diseases 2025-11-15
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Tamsulo… Ended

2024-517642-34-00 Benign prostatic hyperplasia (BPH) 2025-11-10
A Study to Learn How Different Forms of The Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults Ended

2025-522574-36-00 Primary and secondary hypertension, and heart failure 2025-11-04
Single-center, single-dose, open-label, laboratory-blinded, randomized, two-treatment, two-period bioequivalence (BE) study comparing the Te… Ended

2025-523137-25-00 Comparative bioequivalence study in healthy volunteers 2025-11-03
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin. Ended

2024-519849-29-00 No medical condition. 2025-10-27
Randomised, crossover bioequivalence clinical trial of memantine 20 mg capsules versus memantine 20 mg film-coated tablets, after a single o… Ended

2025-523808-75-00 Alzheimer’s disease 2025-10-24
Bioequivalence clinical trial of two formulations of loperamide. Ended

2025-523705-14-00 Healthy volunteers 2025-10-23
An open-label, randomized, single-dose, two-period, two-treatment, crossover bioequivalence study with GP-IMP-001 in healthy male volunteers… Ended

2025-522921-37-00 inteneded for treatment of - active rheumatoid arthriti 2025-10-22
Open-label, randomized, two-period, two-treatment, two-sequence, crossover, balanced, study to assess the bioequivalence between the test pr… Ended

2025-522971-27-00 Bioequivalence study under fasting conditions 2025-10-20
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Tamsulo… Ended

2024-517625-72-00 Benign prostatic hyperplasia (BPH) 2025-10-16
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2025-523325-18-00 Bioequivalence study under fasting conditions 2025-10-15
Bioequivalence clinical trial of two formulations of linagliptin Ended

2025-523384-37-00 Healthy volunteers 2025-10-10
Bioequivalence of Lenvatinib 10 mg Capsules in Healthy Participants Under Fasting Conditions Ended

2025-522259-24-00 No medical condition 2025-10-06
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Lisdexa… Ended

2024-513517-12-00 ADHD 2025-10-01
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in the tre… Ended

2025-522975-27-00 Not applicable (submitted trial is a BE study in health 2025-09-29
Evaluation of bioequivalence of two products containing 600 mg ibuprofen: Ibuprofen Sopharma 600 mg film-coated tablets (Test) vs. Brufen 60… Ended

2025-520572-25-00 No therapeutic indication in the current trial with hea 2025-09-27
Randomized, open-label, replicated single-dose, 4-period, 2-sequence crossover study to assess the comparative bioavailability of test produ… Ended

2025-523054-14-00 not applicable (submitted trial is bioavailability) 2025-09-15